Literature DB >> 26122450

Rubella is eliminated from the Americas.

Tony Kirby.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26122450     DOI： 10.1016/S1473-3099(15)00102-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.

Authors:  Emily A Voigt; Iana H Haralambieva; Beth L Larrabee; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

2.  Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study.

Authors:  Amy K Winter; Brian Lambert; Daniel Klein; Petra Klepac; Timos Papadopoulos; Shaun Truelove; Colleen Burgess; Heather Santos; Jennifer K Knapp; Susan E Reef; Lidia K Kayembe; Stephanie Shendale; Katrina Kretsinger; Justin Lessler; Emilia Vynnycky; Kevin McCarthy; Matthew Ferrari; Mark Jit
Journal:  Lancet Glob Health       Date:  2022-10       Impact factor: 38.927

3.  Epidemiological characteristic of rubella by age group during 12 years after the national introduction of rubella vaccine in Hangzhou, China.

Authors:  Jun Wang; Yuyang Xu; Xiaozhen Wang; Yan Liu; Xiaoping Zhang; Jian Du; Xinren Che; Wenwen Gu; Xuechao Zhang; Wei Jiang; Yi Wang
Journal:  Hum Vaccin Immunother       Date:  2022-03-28       Impact factor: 4.526

4.  Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization.

Authors:  Florin Gorun; Daniel Malita; Ioana Ciohat; Tatjana Vilibic-Cavlek; Horea Feier; Irena Tabain; Marius Craina; Octavian Cretu; Dan Navolan
Journal:  Vaccines (Basel)       Date:  2021-01-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.